Jefferies Group LLC Vir Biotechnology, Inc. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $224,853 - $382,965	12,314 New	12,314 $7,000
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $702,296 - $982,773	-36,808 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $779,961 - $1.47 Million	36,808 New	36,808 $36,000
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $395,100 - $1.25 Million	-15,000 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$25.51 - $43.38 $68,519 - $116,518	2,686 Added 21.81%	15,000 $401,000
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $382,650 - $650,700	15,000 New	15,000 $402,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.